Gene Technology

spot_img

Don't Miss

Vaccine Adverse Effects

Biotech Cannot Be Allowed a Right to Secrecy

In his column Biosafety Now, Dr. Simon Wain-Hobson revisits controversial gain of function research conducted in 2014 funded by US NIH contract HHSN26620070001 which successfully managed to transfer...

The science behind the risk of myocarditis following mRNA vaccination

For far too long the government, its advisors and the media have been maintaining the fiction that criticism of mRNA Covid vaccines is outside of “settled science”. In...

mRNA Flu Jabs Are Coming, or Are They?

Last week the US FDA refused to approve the Moderna mRNA flu vaccine because of the inadequacy of trial design. Right away the virulence and reach of...

Stay up to date with our official bulletins!

Please fill in your details and we will keep you up to date with the truth!

Genetics

Checking the Facts

Government Policy

spot_imgspot_img

Latest Articles

Open Letter to the Directors of Health Insurance Companies

Sent personally to CEOs of Southern Cross, FMG, IAG, UniMed/Accuro, NIB and Partners Life Dear Director  Sometimes information helps us to understand puzzling situations. Business models...

A Very Important Read: What is the Solution to NZ’s Health Crisis?

This is not a doom and gloom article, it documents the extensive benefits of natural, cost effective preventive approaches to health which can help...

Open Letter To The Royal Commissioners on Covid-19 Lessons LearnedPhase 2

Dear Grant Illingworth KC and fellow Commissioners I understand from your latest panui that you are currently assessing theevidence you have gathered in order to...

Provisions of the Gene Tech Bill Are Being Introduced by Stealth.

Frustrated by questions being raised by some political parties which are currently stalling the Gene Technology Bill, government appointed regulators have gone ahead to...

Extreme Agendas of Biotechnology Are Being Put on the Table

ChatGPT founder Sam Altman has joined a clutch of tech billionaires contributing to the US$30 million funding of a biotechnology business called Preventive which aims to "correct...

Hot Topics

spot_imgspot_img